Evidence and Guidance of Hepatitis C Therapy in Pregnancy – AJOG MFM
American Journal of Obstetrics and Gynecology MFM – AJOG MFM shared a post on LinkedIn:
“Hepatitis C remains a massive public health problem, but promise has arrived in direct-acting antivirals (DAAs).
In this review, the authors review the state of the evidence regarding hepatitis C therapy in pregnancy, arriving at a conclusion that while larger prospective trials are being conducted, shared-decision making for HepC therapy in pregnancy should be considered given the potential for pregnancy as a major window to combatting this infection. They also provide guidance on counseling about therapy, open registries, and ongoing trials.”
Title: Hepatitis C Treatment During Pregnancy: Time for a Practice Change
Authors: Karley Dutra, Jonathan M. Fenkel
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Jan 14, 2026, 17:27Giulia Zamagni: Critical Gaps in Machine Learning Models for Fetal Growth Restriction
-
Jan 14, 2026, 17:25Structured Multidisciplinary Pathways for Endometriosis – Fondation Endométriose
-
Jan 14, 2026, 17:23Daniel Roshan: Maternal Nail Polish Use and Potential Fetal Exposure
-
Jan 14, 2026, 17:21Rethinking Soy for Women With Endometriosis – Fertility Plus
-
Jan 14, 2026, 17:19Leili Mohebnasab: Understanding Placental Health Through Epigenetics
-
Jan 14, 2026, 17:17High Estradiol and Placental Pathology in Fresh IVF Pregnancies – Fertility and Sterility
-
Jan 12, 2026, 16:03New Insights Into Estrogen Receptor Alpha Regulation in the Endometrium – Fertility and Sterility
-
Jan 12, 2026, 15:37From Innovation to Practice: Standards for Embryo Diagnostic Trials – Fertility and Sterility
-
Jan 12, 2026, 14:47HFEA Updates Choose a Fertility Clinic Tool to Improve Success Reporting